Accounting for Stock-Based Compensation

A software company reports $2.0 billion of GAAP net income and, in the same press release, $3.5 billion of "adjusted" net income. Most of the $1.5 billion gap is stock-based compensation, added back on the grounds that no cash left the building. Employees who received those shares would be surprised to hear they were not paid.

The awkwardness is real. Stock-based compensation is a cost that never appears on a bank statement, so it sits in a gap between two instincts that are both correct: the company did give up something valuable, and the company did not spend any money. The accounting rules resolve this in a specific way, and understanding how they resolve it explains almost every argument analysts have about the number.

What the rules actually require

Under ASC 718 in US GAAP and IFRS 2 internationally, the mechanics are the same in outline.

Measure at grant date. The cost of an award is its fair value on the day it is granted. For a restricted stock unit that is trivially the share price times the number of units. For an option the company runs a Black-Scholes or lattice model and discloses the inputs it used — expected term, expected volatility, risk-free rate and dividend yield — in the equity footnote. A typical disclosure might read: expected term 6.2 years, volatility 42 percent, risk-free rate 4.1 percent, no dividend, producing a grant-date fair value of about $19 on a $40 strike.

Recognise over the service period. That total value is charged to profit across the vesting period, which is the time the employee has to keep showing up to earn it.

Never remeasure. This is the part people miss. Once fair value is set at grant, an equity-classified award is not revalued for later share price moves. An option that expires worthless still cost the income statement its full grant-date value. An award that quadruples in value costs the income statement nothing extra.

Handle the two kinds of condition differently. A performance condition (hit $1 billion of revenue) is trued up as the probability of vesting changes, so expense can be reversed. A market condition (total shareholder return beats an index) is baked into the grant-date fair value and is never trued up — the expense stands even if the target is missed.

Forfeitures are either estimated up front or recognised as they happen, an accounting policy choice.

Two placement details matter for reading a filing. The expense is not a separate income statement line; it is spread across cost of revenue, research and development and sales and administrative expense, and only the footnote reveals the split. And it is added back on the cash flow statement as a non-cash charge, which is why it shows up so prominently in any operating cash flow bridge.

A concrete case: one grant, four years

On 1 March, a company with 200 million shares outstanding grants 1,000,000 restricted stock units at a share price of $40. The award vests 25 percent a year over four years.

Grant-date fair value is 1,000,000 × $40 = $40 million. That entire amount is now committed to the income statement regardless of what happens to the stock. It is spread over 48 months of service, so $833,333 a month.

Year	Months of service	SBC expense	Shares vesting	Value delivered at $15
1 (Mar–Dec)	10	$8.33m	0	—
2	12	$10.00m	250,000	$3.75m
3	12	$10.00m	250,000	$3.75m
4	12	$10.00m	250,000	$3.75m
5 (Jan–Feb)	2	$1.67m	250,000	$3.75m
Total	48	$40.00m	1,000,000	$15.00m

Now suppose the share price falls to $15 and stays there. Three things follow, and none of them are visible in the expense line.

The expense is wrong in both directions. The company charges $40 million to profit for awards that ultimately deliver $15 million of value to employees. The income statement is overstating the cost of this grant by $25 million, and it will never correct.

The employees are not actually retained. A package worth $40 million at grant is worth $15 million in hand. To keep people, the company grants a refresh — more units, at the lower price, so more shares — and next year's expense includes both the old grant still amortising and the new one. This is the refresh spiral, and it is why stock comp as a share of revenue tends to rise when a share price falls.

The dilution is 0.5 percent per grant year. One million shares on a 200 million base. If the company wants to keep the share count flat, it must buy back the 250,000 shares vesting each year, which at $15 costs $3.75 million of genuine cash — appearing in financing activities, long after the expense was recorded and in a completely different section of the statement.

There is also a tax wrinkle worth knowing. The company's tax deduction arises at vesting or exercise, on the intrinsic value then, not on the grant-date value expensed. The difference runs through the income statement as an excess tax benefit or shortfall, which is why the effective tax rate of a company with large equity awards lurches around with its share price.

How to treat it in a model

Three positions are defensible, and the fourth is not.

• Treat it as a cash-equivalent expense. Deduct stock-based compensation from operating cash flow and from free cash flow, then value the existing share count. This is the simplest honest approach and the one most buy-side models default to.
• Treat it as pure dilution. Add it back to cash flow, but grow the share count explicitly with future grants and net settlement, and discount to a share count several years out. Harder, and more accurate for a company whose grants are lumpy.
• Treat buybacks as the true cost. Net repurchases against the shares issued to employees. If a company spends $2 billion on buybacks and issues $1.8 billion of stock to staff, it returned $200 million to shareholders, not $2 billion.

The indefensible position is adding stock-based compensation back to cash flow and valuing on today's share count. That is the version that appears in most "adjusted free cash flow" presentations, and it silently assumes employees work for nothing.

Key terms

• Grant-date fair value — the award's value on the day it is granted; the total amount that will hit profit.
• Requisite service period — the vesting period over which that value is recognised.
• Performance vs market condition — the first is trued up as vesting probability changes; the second never is.
• Refresh grant — an additional award made to top up employees whose original grant has fallen in value.
• Excess tax benefit — the gap between the tax deduction at exercise and the book expense recognised.